CD4 and neoplasm: In contrast, intratumoral injection of AAA-CD4+ T cells, which were produced from BALB/c mouse CD4+ T cells in B6 mouse-derived Flt3L-DCs pulsed with the tumor lysate elicited potent antitumor immunity against established B16F1.